Cooper Companies Inc (COO) Shares Bought by STA Wealth Management LLC

STA Wealth Management LLC grew its stake in Cooper Companies Inc (NYSE:COO) by 46.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,796 shares of the medical device company’s stock after acquiring an additional 883 shares during the period. STA Wealth Management LLC’s holdings in Cooper Companies were worth $640,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. BlackRock Inc. boosted its stake in Cooper Companies by 0.9% in the first quarter. BlackRock Inc. now owns 3,647,931 shares of the medical device company’s stock valued at $834,681,000 after acquiring an additional 31,592 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Cooper Companies by 4.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 2,730,859 shares of the medical device company’s stock valued at $624,849,000 after acquiring an additional 119,970 shares in the last quarter. Amundi Pioneer Asset Management Inc. boosted its stake in Cooper Companies by 10.1% in the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 1,379,094 shares of the medical device company’s stock valued at $300,476,000 after acquiring an additional 126,156 shares in the last quarter. Westfield Capital Management Co. LP boosted its stake in Cooper Companies by 19.9% in the first quarter. Westfield Capital Management Co. LP now owns 710,938 shares of the medical device company’s stock valued at $162,670,000 after acquiring an additional 117,982 shares in the last quarter. Finally, Frontier Capital Management Co. LLC boosted its stake in Cooper Companies by 6.6% in the first quarter. Frontier Capital Management Co. LLC now owns 699,460 shares of the medical device company’s stock valued at $160,043,000 after acquiring an additional 43,009 shares in the last quarter. Institutional investors and hedge funds own 97.30% of the company’s stock.

In related news, Director Michael Kalkstein sold 1,715 shares of the firm’s stock in a transaction on Wednesday, April 11th. The shares were sold at an average price of $221.66, for a total transaction of $380,146.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.60% of the stock is currently owned by company insiders.

A number of research analysts have issued reports on the stock. Oppenheimer set a $265.00 price target on shares of Cooper Companies and gave the stock a “hold” rating in a report on Friday, June 8th. ValuEngine cut shares of Cooper Companies from a “hold” rating to a “sell” rating in a report on Wednesday, June 6th. Raymond James decreased their price target on shares of Cooper Companies from $275.00 to $270.00 and set an “outperform” rating for the company in a report on Tuesday, June 5th. Zacks Investment Research cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Monday, May 28th. Finally, Goldman Sachs Group assumed coverage on shares of Cooper Companies in a report on Wednesday, April 4th. They issued a “neutral” rating and a $231.00 price target for the company. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and six have issued a buy rating to the stock. Cooper Companies has a consensus rating of “Hold” and a consensus price target of $265.36.

COO stock opened at $226.83 on Thursday. The firm has a market cap of $10.90 billion, a P/E ratio of 23.38, a PEG ratio of 1.75 and a beta of 0.61. The company has a current ratio of 2.76, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. Cooper Companies Inc has a one year low of $216.47 and a one year high of $260.26.

Cooper Companies (NYSE:COO) last released its quarterly earnings results on Thursday, June 7th. The medical device company reported $2.86 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.84 by $0.02. The company had revenue of $631.30 million for the quarter, compared to analyst estimates of $627.49 million. Cooper Companies had a net margin of 5.58% and a return on equity of 17.14%. The firm’s revenue was up 20.8% on a year-over-year basis. During the same quarter last year, the business earned $2.50 earnings per share. research analysts predict that Cooper Companies Inc will post 11.82 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply